ALX Oncology Holdings Stock (NASDAQ: ALXO) stock price, news, charts, stock research, profile.
Open | $5.72 |
Close | $5.60 |
Volume / Avg. | 452.09K / 791.55K |
Day Range | 5.56 - 6.09 |
52 Wk Range | 3.94 - 17.83 |
Market Cap | $299.05M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 20 |
Short Interest | 14.22% |
Days to Cover | 3.59 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ALX Oncology Holdings (NASDAQ:ALXO) through any online brokerage.
Other companies in ALX Oncology Holdings’s space includes: Macrogenics (NASDAQ:MGNX), Inozyme Pharma (NASDAQ:INZY), Zentalis Pharma (NASDAQ:ZNTL), Korro Bio (NASDAQ:KRRO) and Adaptimmune Therapeutics (NASDAQ:ADAP).
There is no analysis for ALX Oncology Holdings.
ALX Oncology Holdings has a consensus price target of $29.22.
The stock price for ALX Oncology Holdings (NASDAQ: ALXO) is $5.7399 last updated July 3, 2024 at 3:38 PM EDT.
There are no upcoming dividends for ALX Oncology Holdings.
ALX Oncology Holdings’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for ALX Oncology Holdings.
ALX Oncology Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.